Drug Utilization Review (DUR) Board

Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

About the Board  

Board Meetings 
July 20, 2022 Agenda

As the Alabama State of Emergency has been lifted, the April 27, 2022 Drug Utilization Review (DUR) Board Meeting will be held in person at the Alabama Medicaid building in Montgomery. Voting Board members must be present to count toward a quorum. A virtual WebEx option will be available on the Medicaid website for the public to attend/observe the meeting, please find the link below. All meetings of this Committee are open to the public. 

Alabama Medicaid DUR Meeting

April 27, 2022

1:00 p.m. (Central Time)

Join from the meeting link:

https://medicaid.webex.com/medicaid/j.php?MTID=me7a6a3af191f386d5612415767456b10

Join by meeting number:

Meeting number (access code): 2590 646 5775

Meeting password: ENtMjJxB522

Tap to join from a mobile device (attendees only):

 
+1-650-479-3208, 25906465775## (United States toll)

Join by phone:

 
+1-650-479-3208 (United States toll)



DUR Board Minutes 2017-2022